MCID: SML025
MIFTS: 22

Small Non-Cleaved Cell Lymphoma malady

Categories: Immune diseases

Aliases & Classifications for Small Non-Cleaved Cell Lymphoma

Aliases & Descriptions for Small Non-Cleaved Cell Lymphoma:

Name: Small Non-Cleaved Cell Lymphoma 38
Lymphoma, Small Noncleaved-Cell 69

Classifications:



Summaries for Small Non-Cleaved Cell Lymphoma

MalaCards based summary : Small Non-Cleaved Cell Lymphoma, also known as lymphoma, small noncleaved-cell, is related to burkitt lymphoma and lymphoma. An important gene associated with Small Non-Cleaved Cell Lymphoma is MYC (MYC Proto-Oncogene, BHLH Transcription Factor). The drugs Cyclophosphamide and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include bone and bone marrow.

Related Diseases for Small Non-Cleaved Cell Lymphoma

Diseases related to Small Non-Cleaved Cell Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 burkitt lymphoma 11.4
2 lymphoma 10.5
3 leukemia 10.0
4 chronic lymphocytic leukemia 9.9
5 lymphoblastic lymphoma 9.9
6 lymphoblastic leukemia 9.9

Graphical network of the top 20 diseases related to Small Non-Cleaved Cell Lymphoma:



Diseases related to Small Non-Cleaved Cell Lymphoma

Symptoms & Phenotypes for Small Non-Cleaved Cell Lymphoma

Drugs & Therapeutics for Small Non-Cleaved Cell Lymphoma

Drugs for Small Non-Cleaved Cell Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 277)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
2
Lenograstim Approved Phase 4,Phase 3,Phase 1,Phase 2 135968-09-1
3
Thiotepa Approved Phase 4,Phase 2,Phase 3 52-24-4 5453
4 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
5 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1
6 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
7 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
8 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
9
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
10
Cytarabine Approved, Investigational Phase 3,Phase 2,Phase 1 147-94-4 6253
11
Etoposide Approved Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
12
Methotrexate Approved Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
13
Vincristine Approved, Investigational Phase 3,Phase 1,Phase 2 2068-78-2, 57-22-7 5978
14
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 83-43-2 6741
15
Prednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-24-8 5755
16
rituximab Approved Phase 3,Phase 2,Phase 1 174722-31-7 10201696
17
Busulfan Approved, Investigational Phase 3,Phase 2,Early Phase 1 55-98-1 2478
18
Fludarabine Approved Phase 2, Phase 3, Phase 1 21679-14-1, 75607-67-9 30751
19
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
20
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
21
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
22
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
23
Levoleucovorin Approved Phase 3,Phase 2,Phase 1 68538-85-2
24
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
25
Hydrocortisone Approved, Vet_approved Phase 3,Phase 2 50-23-7 5754 657311
26
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
27
Piperacillin Approved Phase 3 66258-76-2 43672
28
Tazobactam Approved Phase 3 89786-04-9 123630
29
Vancomycin Approved Phase 3 1404-90-6 441141 14969
30
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
31
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 22916-47-8 4189
32
Ondansetron Approved Phase 3,Phase 2 99614-02-5 4595
33
Aldesleukin Approved Phase 3,Phase 2,Phase 1 85898-30-2, 110942-02-4
34
Cyclosporine Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
35
Captopril Approved Phase 3 62571-86-2 44093
36
Fluconazole Approved Phase 3 86386-73-4 3365
37
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
38
Palivizumab Approved, Investigational Phase 3 188039-54-5
39
Ribavirin Approved Phase 3 36791-04-5 37542
40
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 498142 38904
41
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Phase 1 59-30-3 6037
42
leucovorin Approved, Nutraceutical Phase 3,Phase 2,Phase 1 58-05-9 54575, 6560146 143
43
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
44
Butyric Acid Experimental Phase 3,Phase 2,Phase 1 107-92-6 264
45 Analgesics Phase 3,Phase 1,Phase 2
46 Anesthetics Phase 3
47 Anesthetics, Dissociative Phase 3
48 Anesthetics, General Phase 3
49 Anesthetics, Intravenous Phase 3
50 Central Nervous System Depressants Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 217)
id Name Status NCT ID Phase
1 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4
2 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3
3 Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia Completed NCT00005977 Phase 3
4 TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed NCT00002757 Phase 3
5 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3
6 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3
7 Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Completed NCT00369564 Phase 3
8 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
9 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
10 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3
11 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3
12 Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease Completed NCT00003414 Phase 3
13 A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families Completed NCT00782145 Phase 3
14 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
15 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3
16 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3
17 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3
18 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
19 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
20 Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer Active, not recruiting NCT00003816 Phase 2, Phase 3
21 Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases Unknown status NCT00084695 Phase 2
22 Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy Unknown status NCT00003716 Phase 2
23 Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma Unknown status NCT00003942 Phase 1, Phase 2
24 Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma Unknown status NCT00032149 Phase 1, Phase 2
25 Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma Unknown status NCT00621036 Phase 2
26 Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia Unknown status NCT01016990 Phase 2
27 Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia Unknown status NCT00008164 Phase 2
28 Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation Unknown status NCT00036712 Phase 2
29 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
30 Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia Completed NCT00002494 Phase 2
31 Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas Completed NCT00001237 Phase 2
32 Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL Completed NCT00187161 Phase 2
33 Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma Completed NCT00049036 Phase 2
34 Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003575 Phase 2
35 Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Completed NCT00057811 Phase 2
36 Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment Completed NCT00005811 Phase 2
37 Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma Completed NCT00002691 Phase 2
38 Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma Completed NCT00002738 Phase 2
39 Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00027937 Phase 2
40 Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia Completed NCT00004898 Phase 1, Phase 2
41 Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma Completed NCT00238433 Phase 2
42 Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma Completed NCT00018954 Phase 2
43 Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia Completed NCT00324779 Phase 2
44 Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma Completed NCT00002471 Phase 2
45 Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors Completed NCT00365768 Phase 2
46 Interferon Alfa in Treating Children With HIV-Related Cancer Completed NCT00002621 Phase 2
47 Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy Completed NCT00066599 Phase 2
48 Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00003110 Phase 2
49 Study of @neWorld: A Virtual Community for Children With Cancer Completed NCT00070421 Phase 1, Phase 2
50 Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Completed NCT00002502 Phase 2

Search NIH Clinical Center for Small Non-Cleaved Cell Lymphoma

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Small Non-Cleaved Cell Lymphoma cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Small Non-Cleaved Cell Lymphoma:
Blood stem cell transplantation for hematological diseases
Hematopoietic stem cells for treatment of hematologic malignancies
Embryonic/Adult Cultured Cells Related to Small Non-Cleaved Cell Lymphoma:
Peripheral blood-derived hematopoietic stem cells (family)
Bone marrow-derived hematopoietic stem cells

Genetic Tests for Small Non-Cleaved Cell Lymphoma

Anatomical Context for Small Non-Cleaved Cell Lymphoma

MalaCards organs/tissues related to Small Non-Cleaved Cell Lymphoma:

39
Bone, Bone Marrow

Publications for Small Non-Cleaved Cell Lymphoma

Articles related to Small Non-Cleaved Cell Lymphoma:

(show all 18)
id Title Authors Year
1
Long-term survival in patients with human immunodeficiency virus-associated small non-cleaved cell lymphoma: the role for short course intensive chemotherapy. ( 14579241 )
2003
2
Human herpesvirus-8 (HHV-8) associated with small non-cleaved cell lymphoma in a child with AIDS. ( 10072113 )
1999
3
Diagnosis of small non-cleaved cell lymphoma by fine needle aspiration utilizing cytomorphologic features combined with cytogenetic analysis. ( 9167698 )
1997
4
Genetic heterogeneity of AIDS-related small non-cleaved cell lymphoma. ( 9332331 )
1997
5
Bone marrow involvement in lymphoblastic lymphoma and small non-cleaved cell lymphoma: the role of trephine biopsy. ( 9407729 )
1997
6
Treatment of small non-cleaved cell lymphoma in the adult. ( 8991114 )
1996
7
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. ( 8622041 )
1996
8
Azothymidine and interferon-alpha are active in AIDS-associated small non-cleaved cell lymphoma but not large-cell lymphoma. ( 8814017 )
1996
9
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte. ( 8558204 )
1996
10
Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: further experience with total therapy B. ( 8084306 )
1994
11
Prognostic factors for therapeutic outcome of diffuse small non-cleaved cell lymphoma in adults. ( 8037180 )
1994
12
The role of gallium-67 tumour scintigraphy in patients with small, non-cleaved cell lymphoma. ( 8440267 )
1993
13
Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology. ( 7683228 )
1993
14
Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological, and molecular study. ( 1961039 )
1991
15
Small non-cleaved cell lymphoma in adults. ( 1897513 )
1991
16
Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. ( 2003515 )
1991
17
Pleural effusion is associated with a poor treatment outcome in stage III small non-cleaved cell lymphoma. ( 1999958 )
1991
18
Biology and treatment of small non-cleaved cell lymphoma. ( 2578020 )
1989

Variations for Small Non-Cleaved Cell Lymphoma

Expression for Small Non-Cleaved Cell Lymphoma

Search GEO for disease gene expression data for Small Non-Cleaved Cell Lymphoma.

Pathways for Small Non-Cleaved Cell Lymphoma

GO Terms for Small Non-Cleaved Cell Lymphoma

Sources for Small Non-Cleaved Cell Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....